Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. L...

FDA Drug Recall #D-0208-2025 — Class III — January 16, 2025

Recall Summary

Recall Number D-0208-2025
Classification Class III — Low risk
Date Initiated January 16, 2025
Status Completed
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Appco Pharma LLC
Location Piscataway, NJ
Product Type Drugs
Quantity 1380 bottles

Product Description

Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.

Reason for Recall

Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet

Distribution Pattern

Nationwide USA.

Lot / Code Information

Lot #: 2402101UR, Exp 02/28/2027

Other Recalls from Appco Pharma LLC

Recall # Classification Product Date
D-0419-2026 Class II Prazosin Hydrochloride Capsules, USP, 1mg, 100-... Mar 27, 2026
D-0420-2026 Class II Prazosin Hydrochloride Capsules, USP, 2mg, 100-... Mar 27, 2026
D-0421-2026 Class II Prazosin Hydrochloride Capsules, USP, 5mg, 100-... Mar 27, 2026
D-0648-2020 Class II Ranitidine Capsules 300 mg, 30 count bottles. R... Jan 7, 2020
D-0649-2020 Class II Ranitidine Capsules 150 mg, (a) 60 count bottle... Jan 7, 2020

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.